(Q40149799)

17 September 2017

title

Identification of key residues involved in mediating the in vivo anti-tumor/anti-endothelial activity of Alphastatin (English)

1 reference

17 September 2017

0 references

7

1 reference

17 September 2017

5

Tazzyman S

1 reference

17 September 2017

Staton CA

1

1 reference

17 September 2017

Stribbling SM

2

1 reference

17 September 2017

García-Echeverría C

3

1 reference

17 September 2017

Bury JP

4

1 reference

17 September 2017

Lewis CE

6

1 reference

17 September 2017

publication date

1 April 2007

1 reference

Journal of Thrombosis and Haemostasis

17 September 2017

published in

1 reference

17 September 2017

volume

5

1 reference

17 September 2017

issue

4

1 reference

17 September 2017

page(s)

846-854

1 reference

The hemostatic system as a regulator of angiogenesis

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02432.X

The hemostatic system and angiogenesis in malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02432.X

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02432.X

Fibrinogen E fragment selectively disrupts the vasculature and inhibits the growth of tumours in a syngeneic murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02432.X

Alphastatin, a 24-amino acid fragment of human fibrinogen, is a potent new inhibitor of activated endothelial cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02432.X

Terminal modifications inhibit proteolytic degradation of an immunogenic MART-1(27-35) peptide: implications for peptide vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02432.X

Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02432.X

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02432.X

Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02432.X

The interaction of thrombin with fibrinogen. A structural basis for its specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02432.X

Fibrinopeptide A binds Gly-Pro-Arg-Pro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02432.X

Mechanism of action of thrombin on fibrinogen: NMR evidence for a beta-bend at or near fibrinogen A alpha Gly(P5)-Gly(P4).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02432.X

10.1111/J.1538-7836.2007.02432.X

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference